NewsStjepan Kalinic
iShares U.S. Pharmaceuticals ETF
IHE · ETF
$102.51−$2.27 (−2.17%)TodayMarket closed ·
Prev close $104.78
Latest news
- NewsVandana Singh
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
- NewsChandrima Sanyal
UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs
- NewsRishabh Mishra
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- NewsChandrima Sanyal
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
- NewsChandrima Sanyal
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk
- NewsChandrima Sanyal
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs
- NewsRishabh Mishra
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
- NewsChandrima Sanyal
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
- NewsRishabh Mishra
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
- NewsVishaal Sanjay
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
- NewsChandrima Sanyal
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
- NewsRishabh Mishra
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
- NewsRishabh Mishra
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
- NewsVishaal Sanjay
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
- NewsRishabh Mishra
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
- NewsAnanya Gairola
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
- NewsChandrima Sanyal
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
- NewsNamrata Sen
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
- NewsChandrima Sanyal
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
- NewsSurbhi Jain
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?
- NewsChandrima Sanyal
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
- NewsShivdeep Dhaliwal
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.